2,6-Dichloropurine-9-b-D-riboside

We are 2,6-Dichloropurine-9-b-D-riboside CAS:13276-52-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2,6-Dichloropurine-9-β-D-riboside
CAS.NO:13276-52-3
Synonyms:2,6-Dichloropurine riboside
(2R,3R,4S,5R)-2-(2,6-Dichloro-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
Molecular Formula:C10H10Cl2N4O4
Molecular Weight:321.11700
 
Physical and Chemical Properties:
Density:2.14
Melting point:>190ºC
Boiling point:589.3ºC
Index of Refraction:1.854
 
Specification:
Appearance:White or off-white crystalline powder
Assay(HPLC):≥99.0%
Loss on drying:≤1.0%
Residue on ignition:≤0.5%
Heavy metal:≤20ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:It is an intermediate for antibacterial, antiviral and antitumor drugs.

2,6-Dichloropurine-9-b-D-riboside


Related News: These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders — in addition to Ed Damiano — include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible.5-Bromopyrimidine The target screening performed by Retrogenix will focus on hundreds of novel, prioritized antibodies in Resonant’s collection.3-Amino-5-bromo-2-chloropyridine The acquired pharmaceutical intermediates business will be renamed Corden Pharma Switzerland LLC and will operate as part of ICIG’s pharmaceutical business within the Corden Pharma platform. The companies’ goal is to close the transaction during the first quarter of 2011. Financial terms are not disclosed.Methyl 2-(2-(((benzyloxy)carbonyl)amino)thiazol-4-yl)acetate Inceptua Medicines Access is a business unit of the Inceptua Group. It offers full access solutions for the design, implementation and delivery of Pre-approval and Medicines Access Programs on behalf of biopharmaceutical companies.Some experts said that in the research and development of chemical medicine, the possibility of large medicines is getting smaller and smaller, and with the popularization of precision treatment, small medicines (high-efficiency medicines) are being introduced more and more.

Related Products
Product Name
sodium,4-isothiocyanatobenzenesulfonate,hydrate View Details
2,3,3,3-tetrafluoroprop-1-ene Cas:754-12-1 View Details
3,5-Dichloro-2-fluoropyridine View Details
2-dimethylphosphanylethyl(dimethyl)phosphane manufacturer Ethyl 4,6-dichloropyridazine-3-carboxylate manufacturer 4-(4-aminophenoxy)-N-methylpyridine-2-carboxamide manufacturer sodium iodide manufacturer 2-bromo-1-(3,5-difluorophenyl)ethanone manufacturer